Subscribe to RSS
DOI: 10.1055/s-2004-814418
Diffuse Colonic Polyposis Detected at Screening Colonoscopy: Mantle-Cell Lymphoma
H. C. Wolfsen, M. D.
                     Division of Gastroenterology and Hepatology 
Mayo Clinic
                     
                     4500 San Pablo Road 
Jacksonville, FL 32224 
USA
                     
                     Fax: + 1-904-953-7260
                     
                     Email: pdt@mayo.edu
                     
                     
Publication History
Publication Date:
21 April 2004 (online)

Figure 1 A 63-year-old asymptomatic white man was referred for screening colonoscopy, which detected diffuse polyposis throughout the colon and terminal ileum. Subsequently, similar lesions in the duodenum were found on upper endoscopy. Diffuse abdominal lymphadenopathy and thickened mucosa in the terminal ileum were identified on computed tomography.

Figure 2 Immunohistopathological studies confirmed mantle-cell lymphoma, with a predominance of B cells confirmed with positive CD20, CD5 and cyclin D1 immunostains. Treatment with combination chemotherapy, including rituximab, was initiated.
H. C. Wolfsen, M. D.
         Division of Gastroenterology and Hepatology 
Mayo Clinic
         
         4500 San Pablo Road 
Jacksonville, FL 32224 
USA
         
         Fax: + 1-904-953-7260
         
         Email: pdt@mayo.edu
         
         
H. C. Wolfsen, M. D.
         Division of Gastroenterology and Hepatology 
Mayo Clinic
         
         4500 San Pablo Road 
Jacksonville, FL 32224 
USA
         
         Fax: + 1-904-953-7260
         
         Email: pdt@mayo.edu
         
         

Figure 1 A 63-year-old asymptomatic white man was referred for screening colonoscopy, which detected diffuse polyposis throughout the colon and terminal ileum. Subsequently, similar lesions in the duodenum were found on upper endoscopy. Diffuse abdominal lymphadenopathy and thickened mucosa in the terminal ileum were identified on computed tomography.

Figure 2 Immunohistopathological studies confirmed mantle-cell lymphoma, with a predominance of B cells confirmed with positive CD20, CD5 and cyclin D1 immunostains. Treatment with combination chemotherapy, including rituximab, was initiated.
 
     
      
    